• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲泼尼龙琥珀酸钠与盐酸格拉司琼在 0.9%氯化钠溶液中的配伍稳定性。

Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution.

机构信息

Department of Pharmacy, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

Medicine (Baltimore). 2022 Jul 15;101(28):e29674. doi: 10.1097/MD.0000000000029674.

DOI:10.1097/MD.0000000000029674
PMID:35839031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11132371/
Abstract

A combination of methylprednisolone sodium succinate (MSS) and granisetron hydrochloride (GH) is generally devoted to treating the chemotherapy-induced nausea and vomiting. To date, none of these novel mixtures have been commercially available. The present study was aimed at investigating physical and chemical compatibility and stability of a combination of MSS with GH in 0.9% sodium chloride injection for 72 hours at 4°C and 25°C. A mixture of MSS (0.4-0.8 mg/mL) with GH (0.03 mg/mL) was prepared and stored in both polyvinyl chloride bags and glass bottles using 0.9% sodium chloride injection as a diluent. The study was performed using a validated and stability-indicating high-performance liquid chromatography method. The physical compatibility was assessed by a spectrometer. Furthermore, the pH measurement of each sample was measured electronically. All test solutions stored at 4°C or 25°C had a no >2% loss of the initial concentration throughout the 72-hour study period. All solutions remained clear and colorless throughout the study and were without precipitation or turbidity in any of the batches. The drug mixtures of MSS (0.4-0.8 mg/mL) and GH (0.03 mg/mL) in 0.9% sodium chloride injections were physically and chemically stable for at least 72 hours when stored at 4°C or 25°C in polyvinyl chloride bags or glass bottles.

摘要

甲泼尼龙琥珀酸钠(MSS)和盐酸格拉司琼(GH)的组合通常用于治疗化疗引起的恶心和呕吐。迄今为止,这些新的混合物都没有商品化。本研究旨在研究 MSS 与 GH 在 0.9%氯化钠注射液中的物理和化学相容性以及在 4°C 和 25°C 下 72 小时的稳定性。将 MSS(0.4-0.8mg/mL)与 GH(0.03mg/mL)的混合物用 0.9%氯化钠注射液作为稀释剂分别配制并储存在聚氯乙烯袋和玻璃瓶中。该研究采用经过验证和具有稳定性指示的高效液相色谱法进行。通过分光光度计评估物理相容性。此外,还通过电子方式测量每个样品的 pH 值。在整个 72 小时的研究期间,所有在 4°C 或 25°C 下储存的测试溶液的初始浓度均无 >2%的损失。在整个研究过程中,所有溶液均保持澄清无色,且在任何一批次中均无沉淀或浑浊。当 MSS(0.4-0.8mg/mL)和 GH(0.03mg/mL)的药物混合物在 0.9%氯化钠注射液中于 4°C 或 25°C 下于聚氯乙烯袋或玻璃瓶中储存时,至少在 72 小时内保持物理和化学稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/e2478247c810/medi-101-e29674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/d19c60660933/medi-101-e29674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/988cee943730/medi-101-e29674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/4180fe127161/medi-101-e29674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/93e0a4e08776/medi-101-e29674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/e2478247c810/medi-101-e29674-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/d19c60660933/medi-101-e29674-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/988cee943730/medi-101-e29674-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/4180fe127161/medi-101-e29674-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/93e0a4e08776/medi-101-e29674-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531f/11132371/e2478247c810/medi-101-e29674-g005.jpg

相似文献

1
Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution.甲泼尼龙琥珀酸钠与盐酸格拉司琼在 0.9%氯化钠溶液中的配伍稳定性。
Medicine (Baltimore). 2022 Jul 15;101(28):e29674. doi: 10.1097/MD.0000000000029674.
2
Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.盐酸芬太尼和盐酸纳洛酮在 0.9%氯化钠注射液中用于患者自控镇痛给药的物理相容性和化学稳定性。
Drug Des Devel Ther. 2020 Oct 9;14:4179-4187. doi: 10.2147/DDDT.S248209. eCollection 2020.
3
Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags.布托啡诺与格拉司琼在玻璃瓶或聚烯烃袋包装的0.9%氯化钠注射液中的配伍性。
Am J Health Syst Pharm. 2015 Aug 15;72(16):1374-8. doi: 10.2146/ajhp140824.
4
Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs.盐酸格拉司琼在静脉输液和口服液中的稳定性及与选定药物模拟 Y 型接口注射时的相容性。
Am J Health Syst Pharm. 1996 Feb 1;53(3):294-304. doi: 10.1093/ajhp/53.3.294.
5
Compatible stability of methylprednisolone sodium succinate and tropisetron in 0.9% sodium chloride injection.甲泼尼龙琥珀酸钠与托烷司琼在 0.9%氯化钠注射液中的配伍稳定性。
Eur J Hosp Pharm. 2020 Mar;27(e1):e58-e62. doi: 10.1136/ejhpharm-2018-001693. Epub 2018 Dec 1.
6
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.盐酸昂丹司琼与甲泼尼龙琥珀酸钠在多层聚烯烃容器中的相容性。
Am J Health Syst Pharm. 2005 Oct 1;62(19):2001-5. doi: 10.2146/ajhp040446.
7
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.盐酸伐柔比星(VARUBI)注射用乳剂与静脉注射用盐酸格拉司琼混合后的相容性和稳定性
Int J Pharm Compd. 2018 Jan-Feb;22(1):86-94.
8
Physical compatibility and chemical stability of dezocine and ramosetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.地佐辛和雷莫司琼在 0.9%氯化钠注射液中用于患者自控镇痛给药的物理相容性和化学稳定性。
Medicine (Baltimore). 2022 Nov 11;101(45):e31546. doi: 10.1097/MD.0000000000031546.
9
Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.琥珀酸甲泼尼龙与盐酸西咪替丁在5%葡萄糖注射液中的稳定性及配伍性
Am J Hosp Pharm. 1991 Jun;48(6):1237-41.
10
Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems.曲马多与三种5-羟色胺3受体拮抗剂在用于患者自控给药系统的聚烯烃袋中的稳定性。
Drug Des Devel Ther. 2016 Jun 3;10:1869-75. doi: 10.2147/DDDT.S106665. eCollection 2016.

本文引用的文献

1
Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.盐酸芬太尼和盐酸纳洛酮在 0.9%氯化钠注射液中用于患者自控镇痛给药的物理相容性和化学稳定性。
Drug Des Devel Ther. 2020 Oct 9;14:4179-4187. doi: 10.2147/DDDT.S248209. eCollection 2020.
2
Compatible stability of methylprednisolone sodium succinate and tropisetron in 0.9% sodium chloride injection.甲泼尼龙琥珀酸钠与托烷司琼在 0.9%氯化钠注射液中的配伍稳定性。
Eur J Hosp Pharm. 2020 Mar;27(e1):e58-e62. doi: 10.1136/ejhpharm-2018-001693. Epub 2018 Dec 1.
3
Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration.
雷莫司琼与咪达唑仑在 0.9%氯化钠注射液中用于术后恶心呕吐给药的稳定性和相容性。
Drug Des Devel Ther. 2020 Mar 17;14:1169-1176. doi: 10.2147/DDDT.S244439. eCollection 2020.
4
Y-site Administration of Imipenem/Cilastatin/Relebactam With Common Intravenous Medications.亚胺培南/西司他丁/雷巴他定与常见静脉用药物在 Y 型部位给药。
Clin Ther. 2020 Mar;42(3):475-485. doi: 10.1016/j.clinthera.2020.01.017. Epub 2020 Mar 2.
5
Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.皮质甾类药代动力学和药效动力学建模,第一部分:在大鼠中测定和预测地塞米松和甲泼尼龙的组织结合。
J Pharmacol Exp Ther. 2019 Aug;370(2):318-326. doi: 10.1124/jpet.119.257519. Epub 2019 Jun 13.
6
Drug Treatment of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia).拔毛癖(毛发 pulling 障碍)、皮肤搔抓障碍和咬甲癖(甲床啃咬)的药物治疗。
Curr Neuropharmacol. 2019;17(8):775-786. doi: 10.2174/1570159X17666190320164223.
7
Drug Solubilization by Mixtures of Cyclodextrins: Additive and Synergistic Effects.环糊精混合物对药物的增溶作用:加和与协同效应。
Mol Pharm. 2019 Feb 4;16(2):648-654. doi: 10.1021/acs.molpharmaceut.8b00953. Epub 2019 Jan 16.
8
Managing cyclic vomiting syndrome in children: beyond the guidelines.管理儿童周期性呕吐综合征:超越指南。
Eur J Pediatr. 2018 Oct;177(10):1435-1442. doi: 10.1007/s00431-018-3218-7. Epub 2018 Aug 3.
9
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.盐酸伐柔比星(VARUBI)注射用乳剂与静脉注射用盐酸格拉司琼混合后的相容性和稳定性
Int J Pharm Compd. 2018 Jan-Feb;22(1):86-94.
10
Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies.化疗所致恶心和呕吐概述及循证治疗。
Am J Manag Care. 2017 Sep;23(14 Suppl):S259-S265.